MSG-15: Super-Bioavailability Itraconazole Versus Conventional Itraconazole in the Treatment of Endemic Mycoses—A Multicenter, Open-Label, Randomized Comparative Trial.
Saved in:
| Title: | MSG-15: Super-Bioavailability Itraconazole Versus Conventional Itraconazole in the Treatment of Endemic Mycoses—A Multicenter, Open-Label, Randomized Comparative Trial. |
|---|---|
| Authors: | Spec, Andrej1 (AUTHOR) andrejspec@wustl.edu, Thompson, George R2 (AUTHOR), Miceli, Marisa H3 (AUTHOR), Hayes, Justin4 (AUTHOR), Proia, Laurie5 (AUTHOR), McKinsey, David6 (AUTHOR), Arauz, Ana Belen7 (AUTHOR), Mullane, Kathleen8 (AUTHOR), Young, Jo-Ann9 (AUTHOR), McGwin, Gerald10 (AUTHOR), McMullen, Rachel10,11 (AUTHOR), Plumley, Tyler10 (AUTHOR), Moore, Mary K10 (AUTHOR), McDowell, Lee Ann12 (AUTHOR), Jones, Carolynn11,13 (AUTHOR), Pappas, Peter G10,11 (AUTHOR) andrejspec@wustl.edu |
| Source: | Open Forum Infectious Diseases. Mar2024, Vol. 11 Issue 3, p1-8. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 23288957 |
|---|---|
| DOI: | 10.1093/ofid/ofae010 |
